undefined undefined
NaN.000
NaN.00%
Kintara Therapeutics press release (NASDAQ:KTRA): Q3 GAAP EPS of -$0.05. As of March 31, 2024, Kintara had cash and cash equivalents of approximately $6.35 million. More on Kintara Therapeutics Kintar...
05-15 21:47
Kintara Therapeutics Inc (KTRA) has released an update. Kintara Therapeutics, a...
05-15 05:18
Kintara Therapeutics (NASDAQ:KTRA) reported quarterly losses of $(0.05) per share.
05-15 05:02
Shares of Alphabet Inc. (NASDAQ:GOOGL) (NASDAQ:GOOG) rose sharply in today's pr...
04-26 20:18
NEW YORK, April 5, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may see...
04-06 01:09
NEW YORK, April 4, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...
04-04 22:30
Gainers: ARCA biopharma ABIO +81%. Kintara Therapeutics KTRA +65%. Next.e.GO N.V. EGOX +45%. Vanda Pharmaceuticals VNDA +34%. Aurora Cannabis (ACB) +35%. Educational Development Corp. (EDUC) +29%. Env...
04-04 00:54
Gainers: ARCA biopharma (ABIO) +104%. Kintara Therapeutics (KTRA) +103%. Vanda Pharmaceuticals (VNDA) +26%. Addex Therapeutics ADR (ADXN) +22%. Helius Medical Technologies (HSDT) +19%. Losers: Acorda ...
04-03 22:00
U.S. stocks traded lower this morning, following the release of ADP jobs data on Wednesday. Following the market opening Wednesday, the Dow traded down 0.08% to 39,139.63 while the NASDAQ fell 0.27% to 16,197.58. The S&P 500 also fell, dropping, 0.02% to 5,204.61.
04-03 21:47
Cancer drug developers Kintara Therapeutics (NASDAQ:KTRA) and TuHURA Biosciences agreed to combine in an all-stock transaction on Wednesday to form a new entity called TuHURA Biosciences. The deal, an...
04-03 19:28